The effects of metabolic conditions on prostate cancer incidence over 15 years of follow-up: Results from the Olmsted County Study

BJU International

Volumn 107, Issue 6, 2011, Pages 929-935

  Wallner, Lauren P ^a   Morgenstern, Hal ^b   McGree, Michaela E ^c   Jacobson, Debra J ^c   St Sauver, Jennifer L ^c   Jacobsen, Steven J ^d   Sarma, Aruna V ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Mayo Clinic   (United States)

^d Kaiser Permanente Southern California   (United States)

Author keywords

Diabetes; Hypertension; MeSH: Prostate cancer; Metabolic syndrome; Obesity

Indexed keywords

ADULT; AGED; ANTHROPOMETRY; ARTICLE; CANCER INCIDENCE; CANCER RESEARCH; CAUCASIAN; CLINICAL EXAMINATION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; QUESTIONNAIRE; UNITED STATES;

ADULT; AGED; DIABETES COMPLICATIONS; EPIDEMIOLOGIC METHODS; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MINNESOTA; OBESITY; PROSTATIC NEOPLASMS;

EID: 79952587628     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09703.x     Document Type: Article

References (41)

1. Powell IJ. Epidemiology and pathophysiology of prostate cancer in African-American men. J Urol 2007; 177: 444-9 (Pubitemid 46054044)
2. National Cancer Institute. Estimated new cases and deaths of prostate cancer. National Cancer Institute. 2007. 6-18-0007. Ref Type: Electronic Citation
3. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001; 286: 1195-200 (Pubitemid 33015548)
4. Division of Nutrition and Physical Activity. Overweight and obesity. Centers for Disease Control and Prevention. 2009. 6-20-0007. Ref Type: Electronic Citation
5. Centers for Disease Control and Prevention. Health, United States, 2007. US Department of Health and Human Services, editor. National Center for Health Statistics. 2007. 2-20-2009. Ref Type: Electronic Citation
6. Kumar V, Cotran R, Robbins S. Basic Pathology. Philidelphia: W.B. Saunders Company, 1992
7. Mokdad AH, Ford ES, Bowman BA et al. Diabetes trends in the U.S.: 1990-1998. Diabetes Care 2000; 23: 1278-83
8. Lund HL, Wisloff TF, Holme I, Nafstad P. Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years. Am J Epidemiol 2006; 164: 769-74 (Pubitemid 44522081)
9. Hammarsten J, Hogstedt B. Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer. Blood Press 2004; 13: 47-55 (Pubitemid 38455847)
10. Laukkanen JA, Laaksonen DE, Niskanen L, Pukkala E, Hakkarainen A, Salonen JT. Metabolic syndrome and the risk of prostate cancer in Finnish men: a population-based study. Cancer Epidemiol Biomarkers Prev 2004; 13: 1646-50 (Pubitemid 39331887)
11. Martin RM, Vatten L, Gunnell D, Romundstad P, Nilsen TI. Components of the metabolic syndrome and risk of prostate cancer: the HUNT 2 cohort, Norway. Cancer Causes Control 2009; 20: 1181-92
12. Andersson SO, Wolk A, Bergstrom R et al. Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst 1997; 89: 385-9 (Pubitemid 27102604)
13. Engeland A, Tretli S, Bjorge T. Height, body mass index, and prostate cancer: a follow-up of 950000 Norwegian men. Br J Cancer 2003; 89: 1237-42 (Pubitemid 37363410)
14. Putnam SD, Cerhan JR, Parker AS et al. Lifestyle and anthropometric risk factors for prostate cancer in a cohort of Iowa men. Ann Epidemiol 2000; 10: 361-9 (Pubitemid 30645790)
15. Veierod MB, Laake P, Thelle DS. Dietary fat intake and risk of prostate cancer: a prospective study of 25,708 Norwegian men. Int J Cancer 1997; 73: 634-8 (Pubitemid 127483056)
16. Schuurman AG, Goldbohm RA, Dorant E, van den Brandt PA. Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study. Am J Epidemiol 2000; 151: 541-9 (Pubitemid 30463598)
17. Giovannucci E, Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 2007; 132: 2208-25 (Pubitemid 46693749)
18. Hubbard JS, Rohrmann S, Landis PK et al. Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging. Urology 2004; 63: 253-8 (Pubitemid 38234413)
19. Kasper JS, Giovannucci E. A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 2056-62 (Pubitemid 44877026)
20. Beebe-Dimmer JL, Dunn RL, Sarma AV, Montie JE, Cooney KA. Features of the metabolic syndrome and prostate cancer in African-American men. Cancer 2007; 109: 875-81 (Pubitemid 46333529)
21. Jacobsen SJ, Guess HA, Panser L et al. A population-based study of health careseeking behavior for treatment of urinary symptoms. The Olmsted County Study of Urinary Symptoms and Health Status Among Men. Arch Fam Med 1993; 2: 729-35
22. Jacobsen SJ, Girman CJ, Guess HA, Rhodes T, Oesterling JE, Lieber MM. Natural history of prostatism: longitudinal changes in voiding symptoms in community dwelling men. J Urol 1996; 155: 595-600 (Pubitemid 26023551)
23. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996; 71 : 266-74
24. Cowey S, Hardy RW. The metabolic syndrome: A high-risk state for cancer? Am J Pathol 2006; 169: 1505-22 (Pubitemid 351181984)
25. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Diabetes mellitus and risk of prostate cancer (United States). Cancer Causes Control 1998; 9: 3-9 (Pubitemid 28048654)
26. Rodriguez C, Patel AV, Mondul AM, Jacobs EJ, Thun MJ, Calle EE. Diabetes and risk of prostate cancer in a prospective cohort of US men. Am J Epidemiol 2005; 161: 147-52 (Pubitemid 40096789)
27. Wright ME, Chang SC, Schatzkin A et al. Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer 2007; 109: 675-84 (Pubitemid 46233228)
28. Gong Z, Agalliu I, Lin DW, Stanford JL, Kristal AR. Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men. Cancer 2007; 109: 1192-202 (Pubitemid 46435400)
29. Rodriguez C, Freedland SJ, Deka A et al. Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 2007; 16: 63-9 (Pubitemid 46174265)
30. Freedland SJ, Platz EA. Obesity and prostate cancer: making sense out of apparently conflicting data. Epidemiol Rev 2007; 29: 88-97 (Pubitemid 47229642)
31. Werny DM, Thompson T, Saraiya M et al. Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004. Cancer Epidemiol Biomarkers Prev 2007; 16: 70-6
32. Freedland SJ, Platz EA, Presti JC Jr et al. Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. J Urol 2006; 175: 500-4 (Pubitemid 43067337)
33. Banez LL, Hamilton RJ, Partin AW et al. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA 2007; 298: 2275-80 (Pubitemid 350146217)
34. Gann PH, Daviglus ML, Dyer AR, Stamler J. Heart rate and prostate cancer mortality: results of a prospective analysis. Cancer Epidemiol Biomarkers Prev 1995; 4: 611-6
35. Tande AJ, Platz EA, Folsom AR. The metabolic syndrome is associated with a reduced risk of prostate cancer. Am J Epidemiol 2006; 164: 1094-102 (Pubitemid 44851745)
36. Nakhla AM, Rosner W. Stimulation of prostate cancer growth by androgens and estrogens through the intermediacy of sex hormone-binding globulin. Endocrinology 1996; 137: 4126-9 (Pubitemid 26321856)
37. Laaksonen DE, Niskanen L, Punnonen K et al. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol 2003; 149: 601-8 (Pubitemid 38054707)
38. Burke JP, O'Brien P, Ransom J et al. Impact of case ascertainment on recent trends in diabetes incidence in Rochester, Minnesota. Am J Epidemiol 2002; 155: 859-65 (Pubitemid 34456998)
39. Gades NM, Jacobson DJ, McGree ME et al. Dropout in a longitudinal, cohort study of urologic disease in community men. BMC Med Res Methodol 2006; 6: 58
40. Fowke JH, Signorello LB, Chang SS et al. Effects of obesity and height on prostate-specific antigen (PSA) and percentage of free PSA levels among African-American and Caucasian men. Cancer 2006; 107: 2361-7 (Pubitemid 44748518)
41. Fowke JH, Signorello LB, Underwood W III, Ukoli FA, Blot WJ. Obesity and prostate cancer screening among African-American and Caucasian men. Prostate 2006; 66: 1371-80 (Pubitemid 44350362)